ISAAC DIKE
- Type
- Non-physician practitioner · Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Family
- Where
- FREEPORT, TX
- NPI
- 1508227844
- Received
- $948 in 36 records, 2022 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 19 | $634 |
| 2024 | General payment | 11 | $216 |
| 2023 | General payment | 4 | $68 |
| 2022 | General payment | 2 | $29 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $294 | 2024–2025 |
| ABBVIE INC. | 14 | $266 | 2023–2025 |
| Viatris Specialty LLC | 1 | $121 | 2025 |
| Lilly USA, LLC | 4 | $76 | 2024–2025 |
| Exact Sciences Corporation | 3 | $59 | 2023–2024 |
| Sunovion Pharmaceuticals Inc. | 2 | $29 | 2022 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $28 | 2024–2025 |
| Amgen Inc. | 1 | $22 | 2025 |
| Fidia Pharma USA Inc. | 1 | $19 | 2025 |
| Novo Nordisk Inc | 1 | $16 | 2023 |
| PFIZER INC. | 1 | $13 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 36 | $948 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-11 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-11 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | CREON Drug, ENDOCRINOLOGY | 2025 | |
| 2025-12-09 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-01 | Amgen Inc. | $22 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-10-29 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-14 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-13 | Bayer Healthcare Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-10-07 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2025 | |
| 2025-09-30 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-20 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-08 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-06-17 | Fidia Pharma USA Inc. | $19 | Food and Beverage | In-kind items and services | HYALGAN Device, OSTEOARTHRITIS | 2025 | |
| 2025-05-20 | Viatris Specialty LLC | $121 | Food and Beverage | In-kind items and services | YUPELRI Drug, Anticholinergics, Inhaled | 2025 | |
| 2025-04-29 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-04-29 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-04-01 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-03-03 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-02-19 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2025 | |
| 2025-01-08 | AstraZeneca Pharmaceuticals LP | $210 | Food and Beverage (22 payments) | In-kind items and services | AIRSUPRA Drug, Respiratory | 2025 | |
| 2024-09-19 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-09-05 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2024-08-30 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-08-28 | AstraZeneca Pharmaceuticals LP | $26 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2024 | |
| 2024-08-15 | Exact Sciences Corporation | $18 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2024 | |
| 2024-07-29 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-07-22 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-07-15 | Bayer Healthcare Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-06-27 | Exact Sciences Corporation | $26 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2024 | |
| 2024-06-17 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | MOUNJARO Drug, Diabetes | 2024 | |
| 2024-05-14 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2023-11-09 | Exact Sciences Corporation | $14 | Food and Beverage | In-kind items and services | Cologuard Collection Kit Device, Oncology | 2023 | |
| 2023-07-19 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-06-30 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-01-05 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2022-07-21 | Sunovion Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-06-16 | Sunovion Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Freeport, TX, county Brazoria County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Freeport, TX | County Brazoria County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 10,621 | 391,255 | 30,188,424 |
| Population, 2020 census P1 | 10,696 | 372,031 | 29,145,505 |
| Median age B01002 | 34.5 | 36.7 | 35.6 |
| Under 18 B01001 | 31.5% | 25.6% | 25.0% |
| 65 and over B01001 | 12.1% | 12.8% | 13.4% |
| Households B11001 | 3,877 | 133,898 | 10,992,816 |
| Foreign born B05002 | 15.3% | 14.6% | 17.6% |
| Median household income B19013 | $61,134 | $97,993 | $78,476 |
| Median family income B19113 | $61,346 | $114,938 | $94,599 |
| Per capita income B19301 | $28,967 | $42,527 | $40,752 |
| Poverty rate B17001 | 13.7% | 7.4% | 13.8% |
| Unemployment rate B23025 | 5.7% | 4.7% | 5.3% |
| Civilian labor force B23025 | 4,911 | 192,762 | 15,233,563 |
| Mean commute (minutes) B08013 | 25.3 | 30.6 | 26.7 |
| Bachelor's degree or higher B15003 | 7.2% | 33.1% | 33.8% |
| Housing units B25001 | 5,078 | 150,321 | 12,128,515 |
| Owner-occupied B25003 | 58.8% | 74.1% | 62.6% |
| Renters B25003 | 41.2% | 25.9% | 37.4% |
| Median home value B25077 | $135,900 | $301,600 | $283,800 |
| Median gross rent B25064 | $1,176 | $1,454 | $1,403 |
| White, not Hispanic B03002 | 22.1% | 41.6% | 39.1% |
| Black B03002 | 14.8% | 15.9% | 11.9% |
| Hispanic or Latino B03002 | 59.2% | 31.6% | 39.7% |
| Asian B03002 | 0.0% | 7.4% | 5.5% |
| American Indian and Alaska Native B03002 | 1.3% | 0.2% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Freeport, TX.
Comments